Related Experiment Video

Updated: Apr 27, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

7.1K

Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic

Maneesh Gujrati1, Anthony Malamas, Tesia Shin

  • 1Department of Biomedical Engineering, Case Western Reserve University , Cleveland, Ohio 44106, United States.

Molecular Pharmaceutics
|July 15, 2014
PubMed

Insights

This study introduces ECO, a novel cationic lipid carrier for effective cancer gene therapy. ECO nanoparticles efficiently deliver small interfering RNA (siRNA) into cancer cells, silencing disease genes and showing promise for future treatments.

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Cancer Gene Therapy

Background:

  • Small interfering RNA (siRNA) offers potential for cancer gene therapy by silencing disease-related genes.
  • Efficient siRNA delivery into the cell cytosol is crucial for gene silencing but faces significant barriers.
  • Developing multifunctional delivery systems is essential to overcome these challenges.

Purpose of the Study:

  • To investigate the multifunctional properties and biological activity of a novel cationic lipid carrier, ECO (1-aminoethyl)iminobis[N-(oleicylcysteinyl-1-amino-ethyl)propionamide]).
  • To optimize ECO/siRNA nanoparticle formulations for enhanced intracellular delivery and gene silencing.
  • To evaluate the efficacy and safety of ECO nanoparticles in cancer gene therapy models.

Main Methods:

  • Physicochemical characterization and biological activity assessment of ECO/siRNA nanoparticles at various N/P ratios.
  • Luciferase gene silencing assays in U87 glioblastoma cells to evaluate in vitro efficacy.
  • pH-dependent membrane disruption studies and confocal microscopy to analyze intracellular trafficking and endosomal escape.
  • Assessment of siRNA protection from degradation and glutathione-mediated release mechanisms.

Main Results:

  • Optimized ECO/siRNA nanoparticles demonstrated potent and sustained luciferase silencing in U87 glioblastoma cells, even in serum-containing media.
  • ECO nanoparticles exhibited pH-dependent membrane disruption, facilitating intracellular trafficking.
  • Disulfide linkages in ECO nanoparticles protected siRNA from degradation and enabled glutathione-mediated release in the cytosol.
  • Confocal microscopy confirmed efficient endosomal escape and cytosolic release of siRNA cargo.

Conclusions:

  • The rationally designed multifunctionality of ECO/siRNA nanoparticles is critical for effective intracellular siRNA delivery.
  • ECO nanoparticles represent a promising platform for developing safe and effective siRNA-based cancer gene therapies.
  • Further development of ECO carriers could significantly advance the field of targeted gene silencing for cancer treatment.

More Related Videos

Porous Silicon Microparticles for Delivery of siRNA Therapeutics08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

10.7K
Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy15:55

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

10.1K

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.4K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
156
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
161